Hyperglycemia and steroid use increase the risk of rhino-orbito-cerebral mucormycosis regardless of COVID-19 hospitalization: Case-control study, India.
Ponnaiah M, Ganesan S, Bhatnagar T, Thulasingam M, Majella MG, Karuppiah M, Rizwan SA, Alexander A, Sarkar S, Kar SS, Kadhiravan T, Bhatnagar A, S PK, Pillai VM, Nair PP, Dhodapkar R, Ch Toi P, Singh R, Kasthuri N, Kumar GCP, Jaisankar S, Saini V, Kankaria A, Raj A, Goyal A, Sharma V, Khichar S, Soni K, Garg MK, Selvaraj K, B H S, Bhavana K, Bharti B, Singh CM, Chaudhary N, R V, K G, Palaninathan K, Dube S, Saxena RS, Gupta N, Rathinavel A, Priya S, Arulsundareshkumar, Bellad SA, Kavi A, Harugop AS, Pujary K, Ballala K, Mallya SD, Prasad HM, Ravi D, Balaji NK, Hegde R, Mishra N, Ray S, Karthikeyan S, Ramalingam S, Murali A, Vaidya S, Samadhiya M, Bhojani D, Lakshmanan S, Singh SRB, Pillai N, Deepthi P, Banumathi K, Sumathi V, Ramesh D, Nissar SP, Sheikh KM, Patel MN, Shristava V, Kumar SS, Shantaraman K, Pandian RD, Murhekar M, Aggarwal R.
Ponnaiah M, et al. Among authors: mishra n.
PLoS One. 2022 Aug 8;17(8):e0272042. doi: 10.1371/journal.pone.0272042. eCollection 2022.
PLoS One. 2022.
PMID: 35939442
Free PMC article.
